Health-related problems linked to air pollution could be far higher than previously thought, as researchers have found that short-term exposure to fine particulate matter in the air, known as PM2.5, is associated with several newly identified causes of hospital admissions, even at levels below international air quality guidelines.
Air pollution has, for the first time, been linked to life-threatening illnesses — including sepsis, kidney failure and urinary tract infections, according to the study published in the journal The BMJ.
The study also confirms several previously established causes of hospital admission associated with short-term exposure to PM2.5 including heart and lung diseases, diabetes and Parkinson’s disease.
These associations remained even when the analysis was restricted to days when the PM2.5 concentration was below the WHO air quality guideline.
“Discovered several new causes of hospital admissions associated with short-term exposure to PM2.5 and confirmed several already-known associations, even at daily PM2.5 concentrations below the current WHO guideline,” said study researchers from Harvard Chan School of Public Health in US.
“Economic analysis suggests that even a small increase in short term exposure to PM2.5 is associated with substantial economic effect,” they added.
They also suggested that the WHO air quality guidelines need revising.
For the findings, the research team analysed more than 95 million Medicare hospital insurance claims for adults aged 65 or older in the US from 2000 to 2012.
Causes of hospital admission were classified into 214 mutually exclusive disease groups and these were linked to estimated daily exposure to PM2.5 based on data from the US Environmental Protection Agency.
The researchers then estimated the increased risk of admission and the corresponding costs associated with a 1 ug/m3 increase in short-term exposure to PM2.5 for each disease group.
They found that each 1 ug/m3 increase in PM2.5 was associated with 2,050 extra hospital admissions, 12,216 days in hospital, and $31m (£24m, €28m) in care costs for diseases not previously associated with PM2.5 including sepsis, kidney failure, urinary tract and skin infections.
“Our knowledge of the health effects of PM is still lacking in many areas,” said researchers at the University of Southampton in UK. (IANS)
